Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Dr Reddy

      Dr Reddy's Laboratories Launches Lamotrigine Orally Disintegrating Tablets in US Market

      savita thakur thakur12 Oct 2016 1:12 PM IST
      Hyderabad : Dr. Reddy’s Laboratories Ltd.announced that it has launched Lamotrigine Orally Disintegrating Tablets in 25 mg, 50 mg, 100 mg, and 200 mg,...
      Bristol lung cancer setback puts rival Merck drug in driver seat

      Bristol lung cancer setback puts rival Merck drug in driver seat

      savita thakur thakur12 Oct 2016 1:12 PM IST
      New data is likely to prompt doctors to abandon Bristol-Myers Squibb's immunotherapy Opdivo in favor of Merck & Co's rival Keytruda in a large...
      Exelixis and Pfizer drugs compete in kidney cancer trial

      Exelixis and Pfizer drugs compete in kidney cancer trial

      savita thakur thakur12 Oct 2016 1:11 PM IST
      Copenhagen : Exelixis's drug Cabometyx outperformed Pfizer's Sutent in a clinical study for the treatment of metastatic kidney cancer, suggesting it...
      Piramal Enterprises to acquire Janssen

      Piramal Enterprises to acquire Janssen's injectable anaesthesia, pain management products

      savita thakur thakur11 Oct 2016 12:29 PM IST
      Mumbai : Piramal Enterprises announced that its wholly owned Critical Care subsidiary in the UK has entered into an agreement to acquire five...
      Geistlich dental products to be available in India

      Geistlich dental products to be available in India

      savita thakur thakur11 Oct 2016 10:04 AM IST
      New Delhi : Swiss medical products firm Geistlich Pharma AG said two of its globally patented products used for dental regeneration will now be...
      Mylan to pay $465 mn over EpiPen overcharges to Medicaid

      Mylan to pay $465 mn over EpiPen overcharges to Medicaid

      savita thakur thakur11 Oct 2016 10:02 AM IST
      New York : Mylan will pay $465 million to resolve accusations from some regulators that it over billed the federal Medicaid program for the EpiPen...
      AstraZeneca CEO: Bristol drug flop opens big cancer opportunity

      AstraZeneca CEO: Bristol drug flop opens big cancer opportunity

      savita thakur thakur11 Oct 2016 10:02 AM IST
      Copenhagen : The failure of Bristol-Myers Squibb's blockbuster Opdivo immunotherapy in previously untreated lung cancer patients has opened up the...
      Novartis challenges Pfizer with strong breast cancer drug data

      Novartis challenges Pfizer with strong breast cancer drug data

      savita thakur thakur11 Oct 2016 10:02 AM IST
      An experimental Novartis pill given with an older drug kept advanced breast cancer in check far longer than standard treatment alone, putting it on...
      Revenue Intelligence seizes 100 kg of ALPRAZOLAM from Vizag factory

      Revenue Intelligence seizes 100 kg of ALPRAZOLAM from Vizag factory

      savita thakur thakur10 Oct 2016 12:01 PM IST
      Hyderabad : Directorate of Revenue Intelligence has seized around 100 kgs of alprazolam with a market value of Rs 2.52 crore, allegedly manufactured...
      India’s struggle to introduce dengue vaccines

      India’s struggle to introduce dengue vaccines

      savita thakur thakur10 Oct 2016 11:55 AM IST
      New Delhi : Dengue is a dangerous debilitating disease that occasionally kills people and has no known cure or treatment.Two vaccines against the...
      Ajanta Pharmas Guwahati facility to be ready by Mar 2017

      Ajanta Pharmas Guwahati facility to be ready by Mar 2017

      savita thakur thakur10 Oct 2016 11:53 AM IST
      Mumbai : Drug maker Ajanta Pharma said its new formulations facility at Guwahati will be commercialised before March 2017 and Dahej manufacturing...
      Pfizer to seek more modern headquarters in Manhattan

      Pfizer to seek more modern headquarters in Manhattan

      savita thakur thakur10 Oct 2016 11:52 AM IST
      Pfizer Inc, the largest U.S. drugmaker, said it aims to sell its world headquarters buildings in midtown Manhattan by the end of 2017 and begin moving...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok